These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11150108)

  • 1. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.
    Anttila T; Saikku P; Koskela P; Bloigu A; Dillner J; Ikäheimo I; Jellum E; Lehtinen M; Lenner P; Hakulinen T; Närvänen A; Pukkala E; Thoresen S; Youngman L; Paavonen J
    JAMA; 2001 Jan; 285(1):47-51. PubMed ID: 11150108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
    Koskela P; Anttila T; Bjørge T; Brunsvig A; Dillner J; Hakama M; Hakulinen T; Jellum E; Lehtinen M; Lenner P; Luostarinen T; Pukkala E; Saikku P; Thoresen S; Youngman L; Paavonen J
    Int J Cancer; 2000 Jan; 85(1):35-9. PubMed ID: 10585579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries).
    Hakama M; Luostarinen T; Hallmans G; Jellum E; Koskela P; Lehtinen M; Thoresen S; Youngman L; Hakulinen T
    Cancer Causes Control; 2000 Oct; 11(9):783-90. PubMed ID: 11075866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.
    Madeleine MM; Anttila T; Schwartz SM; Saikku P; Leinonen M; Carter JJ; Wurscher M; Johnson LG; Galloway DA; Daling JR
    Int J Cancer; 2007 Feb; 120(3):650-5. PubMed ID: 17096345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri.
    Luostarinen T; Lehtinen M; Bjørge T; Abeler V; Hakama M; Hallmans G; Jellum E; Koskela P; Lenner P; Lie AK; Paavonen J; Pukkala E; Saikku P; Sigstad E; Thoresen S; Youngman LD; Dillner J; Hakulinen T
    Eur J Cancer; 2004 May; 40(7):1058-65. PubMed ID: 15093583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.
    Kapeu AS; Luostarinen T; Jellum E; Dillner J; Hakama M; Koskela P; Lenner P; Löve A; Mahlamaki E; Thoresen S; Tryggvadóttir L; Wadell G; Youngman L; Lehtinen M
    Am J Epidemiol; 2009 Feb; 169(4):480-8. PubMed ID: 19074773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.
    Safaeian M; Quint K; Schiffman M; Rodriguez AC; Wacholder S; Herrero R; Hildesheim A; Viscidi RP; Quint W; Burk RD
    J Natl Cancer Inst; 2010 Dec; 102(23):1794-804. PubMed ID: 21098758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia trachomatis and cervical squamous cell carcinoma.
    Smith JS; Muñoz N; Franceschi S; Eluf-Neto J; Herrero R; Peeling RW
    JAMA; 2001 Apr; 285(13):1704; author reply 1705-6. PubMed ID: 11277820
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines.
    Smith JS; Muñoz N; Herrero R; Eluf-Neto J; Ngelangel C; Franceschi S; Bosch FX; Walboomers JM; Peeling RW
    J Infect Dis; 2002 Feb; 185(3):324-31. PubMed ID: 11807714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.
    Dillner J; Lehtinen M; Björge T; Luostarinen T; Youngman L; Jellum E; Koskela P; Gislefoss RE; Hallmans G; Paavonen J; Sapp M; Schiller JT; Hakulinen T; Thoresen S; Hakama M
    J Natl Cancer Inst; 1997 Sep; 89(17):1293-9. PubMed ID: 9293920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma.
    Wallin KL; Wiklund F; Luostarinen T; Angström T; Anttila T; Bergman F; Hallmans G; Ikäheimo I; Koskela P; Lehtinen M; Stendahl U; Paavonen J; Dillner J
    Int J Cancer; 2002 Oct; 101(4):371-4. PubMed ID: 12209962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.
    Luostarinen T; af Geijersstam V; Bjørge T; Eklund C; Hakama M; Hakulinen T; Jellum E; Koskela P; Paavonen J; Pukkala E; Schiller JT; Thoresen S; Youngman LD; Dillner J; Lehtinen M
    Int J Cancer; 1999 Mar; 80(6):818-22. PubMed ID: 10074912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of Chlamydia trachomatis seropositivity in patients with cervical cancer].
    Onel M; Küçücük S; Töre G; Ağaçfidan A
    Mikrobiyol Bul; 2013 Oct; 47(4):702-7. PubMed ID: 24237439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis and cervical squamous cell carcinoma.
    Gravitt PE; Castle PE
    JAMA; 2001 Apr; 285(13):1703-4; author reply 1705-6. PubMed ID: 11277819
    [No Abstract]   [Full Text] [Related]  

  • 15. MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
    Discacciati MG; Gimenes F; Pennacchi PC; Faião-Flores F; Zeferino LC; Derchain SM; Teixeira JC; Costa MC; Zonta M; Termini L; Boccardo E; Longatto-Filho A; Consolaro ME; Villa LL; Maria-Engler SS
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1539-47. PubMed ID: 26261088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples.
    Kwaśniewska A; Korobowicz E; Zdunek M; Skoczyński M; Kwaśniewski W; Daniłoś J; Goździcka-Józefiak A
    Eur J Gynaecol Oncol; 2009; 30(1):65-70. PubMed ID: 19317260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.
    Sundström K; Ploner A; Arnheim-Dahlström L; Eloranta S; Palmgren J; Adami HO; Ylitalo Helm N; Sparén P; Dillner J
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26160881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil.
    da Silva Barros NK; Costa MC; Alves RR; Villa LL; Derchain SF; Zeferino LC; Dos Santos Carneiro MA; Rabelo-Santos SH
    J Med Virol; 2012 Jul; 84(7):1143-50. PubMed ID: 22585734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer.
    Paavonen J; Karunakaran KP; Noguchi Y; Anttila T; Bloigu A; Dillner J; Hallmans G; Hakulinen T; Jellum E; Koskela P; Lehtinen M; Thoresen S; Lam H; Shen C; Brunham RC
    Am J Obstet Gynecol; 2003 Nov; 189(5):1287-92. PubMed ID: 14634555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Chlamydia trachomatis and oncogenic human papillomavirus types in cytologic atypia of the uterine cervix.
    Fehér E; Szalmás A
    Acta Microbiol Immunol Hung; 2006 Dec; 53(4):479-87. PubMed ID: 17278714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.